Sonoma Pharmaceuticals (SNOA) Long-Term Investments (2014 - 2015)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Long-Term Investments of $4.5 million in Q1 2015, down 17.49% quarter-over-quarter from $5.5 million in Q4 2014, and down 55.29% on a YoY basis from $10.1 million in Q1 2014.
Sonoma Pharmaceuticals (SNOA) Long-Term Investments (2014 - 2015) Analysis & Trends
Sonoma Pharmaceuticals' Long-Term Investments history runs 2 years deep, the most recent figure standing at $4.5 million for Q1 2015.
- In Q1 2015, Long-Term Investments fell 55.29% year-over-year to $4.5 million; the TTM figure through Mar 2015 stood at $4.5 million (down 55.29% YoY), while the FY2015 annual figure was $4.5 million, down 55.29% from the prior year.
- Long-Term Investments was $4.5 million for Q1 2015 at Sonoma Pharmaceuticals, down from $5.5 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $10.2 million in Q1 2014 to a low of $4.5 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 1.33 Bn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 8.83 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 1.90 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Sonoma Pharmaceuticals | 1.88 Mn | -676,699.96 | 1.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 4.54 Mn |
| Dec 31, 2014 | 5.50 Mn |
| Sep 30, 2014 | 10.15 Mn |
| Mar 31, 2014 | 10.15 Mn |